HIGHLIGHTS
- who: Haitao Miao from the Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Department of Medical have published the research: Application of a Novel 68Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients, in the Journal: (JOURNAL)
- what: In the present study, 68Ga-HER2 PET/CT showed a similar performance with 18 F-FDG in assessing metastases. In this study, a different HER2 uptake was shown on the HER2 PET/CT scan in synchronous primaries confirmed by clinical or pathological diagnosis.
SUMMARY
The spatiotemporal heterogeneity of HER2 expression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.